Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development

scientific article published on 01 April 2001

Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/CARCIN/22.4.665
P698PubMed publication ID11285204

P2093author name stringJ Wang
G Oberhuber
M A Rogy
B Tichy
B G Beinhauer
S Kappel
S Sturlan
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectinflammatory bowel diseasesQ917447
P304page(s)665-671
P577publication date2001-04-01
P1433published inCarcinogenesisQ326022
P1476titleInterleukin-10-deficient mice and inflammatory bowel disease associated cancer development
P478volume22

Reverse relations

cites work (P2860)
Q97521515A Critical Blimp-1-Dependent IL-10 Regulatory Pathway in T Cells Protects From a Lethal Pro-inflammatory Cytokine Storm During Acute Experimental Trypanosoma brucei Infection
Q34359061A novel murine model of inflammatory bowel disease and inflammation-associated colon cancer with ulcerative colitis-like features
Q33598811An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor grow
Q34512820Animal models of colitis-associated carcinogenesis
Q38765886Anti-Oxidant, Pro-Oxidant and Anti-Inflammatory Effects of Unpolished Rice Relevant to Colorectal Cancer
Q53095341Association of IL-10-1082 promoter polymorphism with susceptibility to gastric cancer: evidence from 22 case-control studies.
Q33990371Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer
Q34240789Beta catenin and cytokine pathway dysregulation in patients with manifestations of the "PTEN hamartoma tumor syndrome"
Q35748975CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice
Q38728458Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction
Q33678275Chronic inflammation and cytokines in the tumor microenvironment
Q37339787Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells
Q35169025Colitis-associated neoplasia: molecular basis and clinical translation
Q99561635Deficiency of activation-induced cytidine deaminase in a murine model of ulcerative colitis
Q34349248Dietary vitamin B6 intake modulates colonic inflammation in the IL10-/- model of inflammatory bowel disease
Q34532791Do interleukin polymorphisms play a role in the prevention of colorectal adenoma recurrence by dietary flavonols?
Q26751763Helicobacter pylori associated Asian enigma: Does diet deserve distinction?
Q24648695Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice
Q97519137IL-10 and IL-22 in Mucosal Immunity: Driving Protection and Pathology
Q41884883Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP.
Q36597803Inflammation and colorectal cancer: colitis-associated neoplasia
Q34000619Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (review).
Q55069382Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease.
Q34625607Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells
Q37190102Macrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer
Q36827259Mechanistic roles of epithelial and immune cell signaling during the development of colitis-associated cancer
Q93147388Methyl gallate and tylosin synergistically reduce the membrane integrity and intracellular survival of Salmonella Typhimurium
Q37851008Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications
Q33985578Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models
Q34091635Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis
Q37190457Positive feedback regulation between IL10 and EGFR promotes lung cancer formation
Q34065213Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements
Q34229305Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon
Q41287600Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis
Q28304230Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer
Q45944049Targeting IL-10 Family Cytokines for the Treatment of Human Diseases.
Q84764341Targeting activation-induced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation
Q35117031The gut microbiota in mouse models of inflammatory bowel disease

Search more.